- 4-Week # shares sold: 6,881
- 12-Week # shares sold: 8,301
- 24-Week # shares sold: 25,348
Potential targets of the medical device and diagnostics giant might request stricter parameters when structuring a deal, company followers say.
Trade-Ideas LLC identified C.R. Bard (BCR) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate